MindWalk Holdings Corp.
Business
MindWalk Holdings Corp. is an AI-driven biotherapeutic research and technology firm providing end-to-end antibody discovery and development services that combine in silico platforms with wet-lab capabilities. It offers services and products including custom antibody and protein production, B cell selection and sequencing, phage display libraries, affinity maturation, antibody engineering and characterization, cryostorage, and AI-powered drug discovery platforms (HYFT, LENSai, BioStrand). The company operates through subsidiaries and divisions such as IPA Canada, IPA Europe, BioStrand and Talem, covering CRO services and internal therapeutic discovery. Its services are distributed globally, with significant operations and clients in the United States, Europe, Canada and other international markets.
Summary from filing dated 2025-07-29
Financials
Latest annual snapshot (FY2025, period end 2025-04-30). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-30.20M |
| Total assets | $44.44M |
| Total liabilities | $20.82M |
| Stockholders' equity | — |
| Operating cash flow | — |